Eolo Pharma

OverviewSuggest Edit

EOLO Pharma is a clinical research company. It focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases (e.g. type II diabetes, autoimmune, metabolic syndrome, hypertension, atherosclerosis, etc.)


Latest Updates

Cybersecurity ratingBMore

Eolo Pharma Financials and Metrics

Summary Metrics

Founding Date


Eolo Pharma total Funding

$2.7 m

Eolo Pharma latest funding size

$2.70 m

Time since last funding

a year ago

Eolo Pharma investors

Eolo Pharma's latest funding round in January 2020 was reported to be $2.7 m. In total, Eolo Pharma has raised $2.7 m
Show all financial metrics

Eolo Pharma Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Eolo Pharma Online and Social Media Presence

Embed Graph

Eolo Pharma Frequently Asked Questions

  • When was Eolo Pharma founded?

    Eolo Pharma was founded in 2017.

  • Who are Eolo Pharma competitors?

    Competitors of Eolo Pharma include NovaLead Pharma, Aepodia and GSK.